Format

Send to

Choose Destination
Epilepsia. 2014 Nov;55(11):1705-13. doi: 10.1111/epi.12810. Epub 2014 Sep 29.

Genetic testing preferences in families containing multiple individuals with epilepsy.

Author information

1
GH Sergievsky Center, Columbia University, New York, New York, U.S.A; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, U.S.A.

Abstract

OBJECTIVE:

To examine genetic testing preferences in families containing multiple individuals with epilepsy.

METHODS:

One hundred forty-three individuals with epilepsy and 165 biologic relatives without epilepsy from families containing multiple affected individuals were surveyed using a self-administered questionnaire. Four genetic testing scenarios were presented, defined by penetrance (100% vs. 50%) and presence or absence of clinical utility. Potential predictors of genetic testing preferences were evaluated using generalized estimating equations with robust Poisson regression models. The influence of 21 potential testing motivations was also assessed.

RESULTS:

For the scenario with 100% penetrance and clinical utility, 85% of individuals with epilepsy and 74% of unaffected relatives responded that they would definitely or probably want genetic testing. For the scenario with 100% penetrance but without clinical utility, the proportions who responded that they would want testing were significantly lower in both affected individuals (69%) and unaffected relatives (57%). Penetrance (100% vs. 50%) was not a significant predictor of genetic testing interest. The highest-ranking motivations for genetic testing were the following: the possibility that the results could improve health or health care, the potential to know if epilepsy in the family is caused by a gene, and the possibility of changing behavior or lifestyle to prevent seizures.

SIGNIFICANCE:

Interest in epilepsy genetic testing may be high in affected and unaffected individuals in families containing multiple individuals with epilepsy, especially when testing has implications for improving clinical care.

KEYWORDS:

Epidemiology; Epilepsy; Genetic testing; Genetics; Patient preferences

PMID:
25266816
PMCID:
PMC4232990
DOI:
10.1111/epi.12810
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center